Regeneron (REGN) (RIMM) (SAP) (CRL) (CTCT) (DDD) Ratings Reiterated

Regeneron Pharma (NASDAQ: REGN), Research In Motion (NASDAQ: RIMM), SAP Aktiengesellschaft (NYSE: SAP), Charles River Laboratories (NYSE: CRL), Constant Contact (NASDAQ: CTCT) and 3D Systems Co. (NYSE: DDD) had ratings on them reiterated by analysts.

Robert W. Baird reiterated its "Neutral" rating on Regeneron Pharma (REGN).

JPMorgan Chase & Co. (NYSE:JPM) reiterated its "Neutral" rating on Research In Motion (RIMM). They have a price target of $17.00 on the company.

Nomura reiterated its "Positive" rating on SAP Aktiengesellschaft (SAP).

Sterne Agee reiterated its "Buy" rating on Charles River Laboratories (CRL). They have a price target of $43.00 on the company.

Needham & Company reiterated its "Buy" rating on Constant Contact (CTCT).

Needham & Company reiterated its "Buy" rating on 3D Systems Co. (DDD).